XML 47 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information (Tables)
 9 Months Ended
Oct. 03, 2020
Segment Information [Abstract]  
Segment Reporting Information by Segment
The following tables set forth business segment information:

   
MOSFETs
    
Diodes
    
Optoelectronic
Components
    
Resistors
    
Inductors
    
Capacitors
    
Corporate / Other*
    
Total
  
Fiscal quarter ended October 3, 2020:
                                            
Net revenues
  
$
133,976
    
$
123,744
    
$
64,955
    
$
145,362
    
$
79,399
    
$
92,724
    
$
-
    
$
640,160
  
                                                                 
Gross profit
  
$
29,649
    
$
20,843
    
$
21,289
    
$
35,186
    
$
26,597
    
$
18,387
    
$
(242
)
  
$
151,709
  
                                                                 
Segment operating income
  
$
20,148
    
$
15,828
    
$
17,184
    
$
30,127
    
$
24,106
    
$
13,703
    
$
(242
)
  
$
120,854
  
                                                                 
Fiscal quarter ended September 28, 2019:
                                                          
Net revenues
  
$
126,747
    
$
123,879
    
$
50,702
    
$
155,119
    
$
73,458
    
$
98,424
    
$
-
    
$
628,329
  
                                                                 
Gross profit
  
$
30,491
    
$
21,138
    
$
10,883
    
$
42,444
    
$
23,450
    
$
21,673
    
$
-
    
$
150,079
  
                                                                 
Segment operating income
  
$
21,018
    
$
16,420
    
$
6,923
    
$
36,900
    
$
20,797
    
$
16,675
    
$
-
    
$
118,733
  
Nine fiscal months ended October 3, 2020:
                                            
Net revenues
  
$
369,813
    
$
363,274
    
$
168,264
    
$
444,982
    
$
218,369
    
$
270,016
    
$
-
    
$
1,834,718
  
                                                                 
Gross Profit
  
$
84,779
    
$
65,265
    
$
47,602
    
$
112,472
    
$
69,836
    
$
53,960
    
$
(4,295
)
  
$
429,619
  
                                                                 
Segment Operating Income
  
$
56,408
    
$
50,064
    
$
35,818
    
$
96,891
    
$
62,129
    
$
39,297
    
$
(4,295
)
  
$
336,312
  
                                                                 
Nine fiscal months ended September 28, 2019:
                                                          
Net revenues
  
$
392,930
    
$
433,761
    
$
171,939
    
$
509,309
    
$
222,122
    
$
328,667
    
$
-
    
$
2,058,728
  
                                                                 
Gross Profit
  
$
98,483
    
$
93,487
    
$
43,131
    
$
151,910
    
$
71,268
    
$
77,560
    
$
-
    
$
535,839
  
                                                                 
Segment Operating Income
  
$
70,237
    
$
78,558
    
$
30,655
    
$
134,914
    
$
63,213
    
$
62,402
    
$
-
    
$
439,979
  

*Amounts reported in Corporate/Other above represent unallocated costs directly related to the COVID-19 outbreak, which are reported as costs of products sold on the consolidated condensed statements of operations.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated
 
Fiscal quarters ended
    
Nine fiscal months ended
  
   
October 3, 2020
    
September 28, 2019
    
October 3, 2020
    
September 28, 2019
  
Reconciliation:
                        
Segment Operating Income
  
$
120,854
    
$
118,733
    
$
336,312
    
$
439,979
  
Restructuring and Severance Costs
    
-
      
(7,255
)
    
(743
)
    
(7,255
)
Impact of COVID-19 on Selling, General, and Administrative Expenses
    
441
      
-
      
871
      
-
  
Unallocated Selling, General, and Administrative Expenses
    
(59,805
)
    
(60,450
)
    
(186,742
)
    
(194,472
)
Consolidated Operating Income
  
$
61,490
    
$
51,028
    
$
149,698
    
$
238,252
  
Unallocated Other Income (Expense)
    
(15,766
)
    
(6,846
)
    
(38,100
)
    
(23,234
)
Consolidated Income Before Taxes
  
$
45,724
    
$
44,182
    
$
111,598
    
$
215,018
  
Disaggregation of Revenue
The Company has a broad line of products that it sells to OEMs, EMS companies, and independent distributors.  The distribution of sales by customer type is shown below:

  
Fiscal quarters ended
    
Nine fiscal months ended
  
   
October 3, 2020
    
September 28, 2019
    
October 3, 2020
    
September 28, 2019
  
Distributors
  
$
325,695
    
$
317,385
    
$
980,703
    
$
1,097,365
  
OEMs
    
273,664
      
263,983
      
725,592
      
815,645
  
EMS companies
    
40,801
      
46,961
      
128,423
      
145,718
  
Total Revenue
  
$
640,160
    
$
628,329
    
$
1,834,718
    
$
2,058,728
  
Net revenues were attributable to customers in the following regions:

  
Fiscal quarters ended
    
Nine fiscal months ended
  
   
October 3, 2020
    
September 28, 2019
    
October 3, 2020
    
September 28, 2019
  
Asia
  
$
270,451
    
$
231,999
    
$
748,160
    
$
737,918
  
Europe
    
213,296
      
231,677
      
626,276
      
765,318
  
Americas
    
156,413
      
164,653
      
460,282
      
555,492
  
Total Revenue
  
$
640,160
    
$
628,329
    
$
1,834,718
    
$
2,058,728
  
The Company generates substantially all of its revenue from product sales to end customers in the industrial, automotive, telecommunications, computing, consumer products, power supplies, military and aerospace, and medical end markets.  Sales by end market are presented below:

  
Fiscal quarters ended
    
Nine fiscal months ended
  
   
October 3, 2020
    
September 28, 2019
    
October 3, 2020
    
September 28, 2019
  
Industrial
  
$
209,473
    
$
205,670
    
$
651,461
    
$
738,043
  
Automotive
    
216,641
      
212,222
      
552,418
      
627,588
  
Telecommunications
    
27,845
      
34,409
      
91,033
      
132,251
  
Computing
    
51,032
      
47,923
      
151,974
      
143,675
  
Consumer Products
    
33,353
      
23,401
      
76,477
      
87,936
  
Power Supplies
    
29,112
      
31,103
      
86,482
      
90,704
  
Military and Aerospace
    
40,582
      
41,872
      
125,968
      
137,281
  
Medical
    
32,122
      
31,729
      
98,905
      
101,250
  
Total revenue
  
$
640,160
    
$
628,329
    
$
1,834,718
    
$
2,058,728